<DOC>
	<DOCNO>NCT00889928</DOCNO>
	<brief_summary>The study document able successfully remove subject 's gallbladder vagina ( laparoscopic visualization ) use small collection study surgical tool .</brief_summary>
	<brief_title>A Trial Evaluate Natural Orifice Transvaginal Endoscopic Cholecystectomy With Laparoscopic Assistance</brief_title>
	<detailed_description />
	<mesh_term>Gallbladder Diseases</mesh_term>
	<criteria>Inclusion Criteria Women enrol study : 1 . Are willing give consent comply evaluation treatment schedule , able understand complete study questionnaire ; 2 . At least 18 year age ; 3 . Have clinical diagnosis gallbladder disease indicate cholecystectomy ; 4 . ASA Classification I II ( Appendix II ) ; 5 . Have negative serum pregnancy test ( woman childbearing potential ) ; 6 . Absence , visual inspection , adhesion judge potentially complicate factor transvaginal access operation . Exclusion Criteria Subjects exclude study follow : 1 . BMI &gt; 35 ; 2 . Use immunosuppressive medication ( within 6 month surgery ; single burst dosage inhalable steroid acceptable ) ; 3 . Suspicion gallbladder cancer , tumor , polyp , mass ; 4 . Acute cholecystitis acute pancreatitis ; 5 . Presence common bile duct stone ; 6 . History cervical vaginal cancer ( precancerous finding recent Pap Test ) ; 7 . Pelvic Inflammatory Disease ; 8 . Evidence abdominal abscess mass ; 9 . Diffuse peritonitis ; 10 . Use anticoagulant antiplatelet agent ( use daily cardio protective dos aspirin , 81 mg/day , acceptable shall constitute exclusion criterion ) presence coagulopathy ; 11 . Clinical diagnosis sepsis ; 12 . History ectopic pregnancy , pelvic inflammatory disease , severe endometriosis ; 13 . History peritoneal vaginal trauma ; 14 . Comorbid condition ( ) could limit subject 's ability participate study comply followup requirement , could impact scientific integrity trial ; 15 . Planned concurrent surgical procedure ; 16 . Prior plan major surgical procedure within 30 day study procedure ; 17 . History transvaginal surgery ; 18 . History ( symptomatic ) abdominal adhesion ; 19 . Participation investigational device drug trial complete primary endpoint clinically interfere current study endpoint ; 20 . Previously enrol current series 4 trial investigate EES NOTES GEN1 Toolbox ; 21 . Any contraindication list study device Instructions Use ( IFU ) document ( device may use study procedure ) ; 22 . Any condition precludes compliance study ( Investigator discretion ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>gallbladder disease</keyword>
	<keyword>cholecystectomy</keyword>
	<keyword>gallbladder disease indicate cholecystectomy</keyword>
</DOC>